Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07099001 · ClinicalTrials.gov registry record · NA

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

A NA study of Cognitive Decline and Alzheimer Disease (AD), sponsored by Qure Healthcare.

Completed
Registry status
NA
Development phase
178
Enrollment target
1
Study location

NCT07099001 is a NA study of Cognitive Decline and Alzheimer Disease (AD) that has completed, run by Qure Healthcare. The registered enrollment target is 178 participants, below the 1,147-participant average among 61 other Cognitive Decline trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07099001, a NA study of Cognitive Decline and Alzheimer Disease (AD), has completed, sponsored by Qure Healthcare.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target
1
Study location

Study Summary

This is a national-level research study of neurologists and dementia specialists. The purpose of this study is to assess the clinical evaluation and management recommendations made by practicing providers for patient simulations with symptoms of cognitive decline.

Conditions Studied

Cognitive Decline Alzheimer Disease (AD)

Interventions

  • OTHER Educational materials on the Alzheimer's disease assay
  • OTHER Alzheimer's disease assay results

Study Locations (1)

Missouri

  • QURE Healthcare - St Louis

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2025-08-08
Est. Completion 2025-12-31
Phase NA

Sponsor

Qure Healthcare

21 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07099001

The ClinicalTrials.gov registry entry for NCT07099001 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,147-participant average among 61 other Cognitive Decline trials with a reported enrollment target (84% lower). The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Educational materials on the Alzheimer's disease assay is the first listed.

NCT07099001 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT07099001 about?

NCT07099001 is a clinical study titled "Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay". This is a national-level research study of neurologists and dementia specialists. The purpose of this study is to assess the clinical evaluation and management recommendations made by practicing providers for patient simulations with symptoms of cognitive decline.

What is the current status of trial NCT07099001?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2025-08-08. Estimated completion is 2025-12-31.

What conditions does trial NCT07099001 study?

This clinical trial studies the following conditions: Cognitive Decline, Alzheimer Disease (AD).

What interventions are being tested in trial NCT07099001?

The interventions under investigation include: Educational materials on the Alzheimer's disease assay (OTHER), Alzheimer's disease assay results (OTHER).

Who is sponsoring clinical trial NCT07099001?

This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07099001 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cognitive Decline

All registered trials for this condition

Alzheimer Disease (AD)

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.